EMFLAZA
NDC 52856-505, deflazacort, suspension, from PTC Therapeutics, Inc..
- Product NDC
- 52856-505
- Status
- Listed
- Labeler
- PTC Therapeutics, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208685
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52856-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFLAZACORT22.75 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52856-505-22 | 52856050522 | 13 mL in 1 BOTTLE (52856-505-22) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/31b347d2-f156-4055-9d8f-7cf0df420296
Use it
Look up 52856-505 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52856-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52856-505. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.